• Ownership

Gwen A. Melincoff - Insider Trading & Ownership

Entity
Individual
Location
C/O Tobira Therapeutics, Inc., 701 Gateway Boulevard, South San Francisco, CA
Summary
The estimated net worth of Gwen A. Melincoff is at least $1.81M dollars as of June 26, 2024. Gwen A. Melincoff is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.69M. Gwen A. Melincoff is the Director of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $87.9K. Gwen A. Melincoff is the Director of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $24.3K.
All Insider Reports
All Insider Reports

Ownership of Gwen A. Melincoff

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COLL COLLEGIUM PHARMACEUTICAL, INC Director $1.69M May 16, 2024
GANX Gain Therapeutics, Inc. Director $87.9K Jun 24, 2024
SLNO SOLENO THERAPEUTICS INC Director $24.3K May 25, 2023
PLX Protalix BioTherapeutics, Inc. Director Sep 29, 2023

Insider Transactions Reported by Gwen A. Melincoff:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.